期刊文献+
共找到3,792篇文章
< 1 2 190 >
每页显示 20 50 100
Expression of proliferating cell nuclear antigen and CD44 variant exon 6 in primary tumors and corresponding lymph node metastases of colorectal carcinoma with Dukes'stage C or D 被引量:37
1
作者 Ji-ChenqZhang Zuo-RenWang +5 位作者 Yan-JuanCheng Ding-ZhongYang Jing-SenShi Ai-LinLiang Ning-NaLiu Xiao-MinWang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2003年第7期1482-1486,共5页
AIM: To study changes in characteristics of colorectal carcinoma during the metastatic process and to investigate the correlation between cell proliferation activity and metastatic ability of patients with Dukes′ sta... AIM: To study changes in characteristics of colorectal carcinoma during the metastatic process and to investigate the correlation between cell proliferation activity and metastatic ability of patients with Dukes′ stage C or D.METHODS: Formalin fixed and paraffin embedded materials of primary tumors and corresponding lymph node metastases resected from 56 patients with Dukes′ stage C or D of colorectal carcinoma were stained immunohistochemically with proliferating cell nuclear antigen (PCNA) and CD44variant exon 6 (CD44v6).RESULTS: Thirty-one of 56 patients (55.4 %) expressed PCNA in the primary sites and 36 of 56 patients (64.3 %)expressed PCNA in the metastatic lymph nodes. A significant relation in PCNA expression was observed between the primary site and the metastatic lymph node (0.010<P<0.025).Forty-one of 56 patients (73.2 %) expressed CD44v6 in the primary site and 39 of 56 patients (69.6 %) expressed CD44v6 in the metastatic lymph node. There was also an significant relationship of CD44v6 between the primary site and the metastatic lymph node (0.005<P<0.010). No difference was observed between expression of CD44v6 and PCNA in the primary site (0.250<P<0.500).CONCLUSION: This study partially demonstrates that tumor cells in metastatic lymph node of colorectal carcinoma still possess cell proliferation activity and metastatic ability of tumor cells in primary site. There may be no association between cell proliferation activity and metastatic ability in colorectal carcinoma. 展开更多
关键词 结肠直肠癌 淋巴结转移癌 细胞增殖 cd44v6 增殖细胞核抗原
下载PDF
Activation of killer cells with soluble gastric cancer antigen combined with anti-CD3 McAb 被引量:5
2
作者 CHEN Qiang, YE Yun Bin and CHEN Zeng 《World Journal of Gastroenterology》 SCIE CAS CSCD 1999年第2期91-92,共2页
INTRODUCTIONTherehavebeenmanyreportsoncancertherapywithlymphokineactivatedkiler(LAK)celsandinterleukin2(IL... INTRODUCTIONTherehavebeenmanyreportsoncancertherapywithlymphokineactivatedkiler(LAK)celsandinterleukin2(IL2),buttheprolife... 展开更多
关键词 STOMACH neoplasms antigens NEOPLASM KILLER cells INTERLEUKIN 2 cd3 McAb
下载PDF
Detection of microbial antigenic components of circulating immune complexes in HIV patients:Involvement in CD4^+ T lymphocyte count depletion
3
作者 Ezeani Michael Chukwudi Onyenekwe CC +7 位作者 Wachukwu CK Anyiam DCD Meludu SC Ukibe RN Ifeanyichukwu M Onochie A Anahalu I Okafor UU 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2010年第10期828-832,共5页
Objective:To investigate the prevalence of microbial antigenic components of circulating immune complexes amongst grades of CD4 T lymphocyte counts in HIV sero positive and seronegative participants.Methods:Polyethele... Objective:To investigate the prevalence of microbial antigenic components of circulating immune complexes amongst grades of CD4 T lymphocyte counts in HIV sero positive and seronegative participants.Methods:Polyethelene glycol(PEG-600) and buffering methods of precipitation and dissociation of immune complexes was used to generate immune solution from sera of 100 HIV sero-positive and 100 HIV sero-negative participants.These were categorized into 3 grades based on CD4 count:】 500 cell/mm,200-499 cell/mm3 and 【200 cell/mm3.The immune solutions were assayed using membrane based immunoassay and antibody titration, along side its unprocessed serum for detection of various microbial antigens and or antibodies. CD4 T cell counts were estimated using Patec Cyflow SL-3 Germany.Results:Antigenic component of immune complexes of various infectious agents was detected in 99 and 70 HIV seropositive and HIV sero-negative participants,respectively.In group A,there were 10 HIV positive participants,including 4(40.0%) had circulating immune complexes(CICs) due to Salmonella species only:1(10.0%) due to Salmonella-Plasmodium falciparum(P.falciparum),SalmonellaP. falciparum-HCV and P.falciparum antigens,respectively.In group B,45(45.4%) HIV seropositive participants with CICs had CD4 T lymphocyte count between 200-499 cells/mm^3.Out of these,20(44.4%) had CICs due to Salmonella species only:9(20%) due to Salmonella-P. falciparum.In group C,there were 44(44.4%) HIV sero-positive participants,including 3(6.8%) due to Salmonella species only:24(54.4%) due to Salmonella-P.falciparum:2(4.5%) due to P. falciparum only.Conclusions:In HIV sero-positive participants,presence of heterogeneity of Salmonella species-P.falciparum antigens was highly incriminated in CD4 count depletion but not homogeneity of malaria parasites antigens.Malaria parasites antigens only were incriminated in CD4^+ count depletion amongst HIV sero-negative participants.Before taking any decision on the management of HIV-1-positive individuals,their malaria and Salmonella paratyphi status should be assessed,but not malaria status alone. 展开更多
关键词 HIV/AIDS Immune complexes MICROBIAL antigenS HIV positive PARTICIPANT cd4^+ LYMPHOCYTE COUNT
下载PDF
Rejection of Experimental Hodgkins Lymphoma by T-Cells Engineered with a CD19 Chimeric Antigen Receptor
4
作者 Anna Swanson Eleanor Cheadle +3 位作者 David Gilham Dorothy Crawford Simon Talbot Ingo Johannessen 《Journal of Cancer Therapy》 2012年第5期553-561,共9页
T cells engineered to express chimeric antigen receptors (CARs) combining an external antibody binding domain with the CD3ζ T cell receptor (TCR) signaling domain for triggering cell activation are being used for imm... T cells engineered to express chimeric antigen receptors (CARs) combining an external antibody binding domain with the CD3ζ T cell receptor (TCR) signaling domain for triggering cell activation are being used for immunotherapeutic targeting of tumor cells in a non-HLA restricted manner. In this study we transduced T cells with a CD19-CAR construct containing a truncated CD34 gene (tCD34) marker and used these to target the B cell antigen CD19 on the surface of a Hodgkin’s lymphoma (HL) cell line (L591) both in vitro and in vivo. Levels of tCD34 expression in transduced peripheral blood mononuclear cells (PBMCs) ranged from 6% - 20% and this was increased to 82% after selection for transduced tCD34+ cells. In vitro cytotoxicity testing on a CD19+ HL cell line (L591) showed specific cell lysis initiated by the CD19-CAR transduced PBMCs. Importantly, CD19-CAR T cells prevented the growth of L591 HL tumor cells when co-injected subcutaneously (sc) in 6/6 severe combined immunodeficient (SCID) mice. There was no evidence of anti-tumor activity when CD19-CAR T cells were infused intravenously (iv) at the same time as L591 HL tumor cells were injected sc. However, 3/6 SCID mice showed tumor rejection within 83 days after iv infusion of CD19-CAR T cells 3 - 9 days after establishment of L591 HL tumors, while all control animals succumbed to tumors within 60 days. Interestingly, immuno-histochemical analysis of L591 HL tumors demonstrated that CD19-CAR T cells were detected not earlier than 11 days after infusion within the tumor mass. These results suggest that CD19 is a potentially attractive target for the immunotherapy of HL. 展开更多
关键词 Hodgkin’s LYMPHOMA cd19 CHIMERIC antigen Receptor Immunotherapy
下载PDF
Regulatory T cells suppress autoreactive CD4^+ T cell response to bladder epithelial antigen
5
作者 Wu-Jiang Liu Yi Luo 《World Journal of Immunology》 2016年第2期105-118,共14页
AIM: To investigate the role of regulatory T (Treg) cells in CD4^+ T cell-mediated bladder autoimmune infammation. METHODS: Urothelium-ovalbumin (URO-OVA)/OT-II mice, a double transgenic line that expresses the... AIM: To investigate the role of regulatory T (Treg) cells in CD4^+ T cell-mediated bladder autoimmune infammation. METHODS: Urothelium-ovalbumin (URO-OVA)/OT-II mice, a double transgenic line that expresses the membrane form of the model antigen (Ag) OVA as a self-Ag on the urothelium and the OVA-specific CD4^+ T cell receptor specifc for the I-Ab/OVA323-339 epitope in the periphery, were developed to provide an autoimmune environment for investigation of the role of Treg cells in bladder autoimmune infammation. To facilitate Treg cell analysis, we further developed URO-OVA^GFP-Foxp3/OT-II mice, a derived line of URO-OVA/OT-II mice that express the green fuorescent protein (GFP)-forkhead box protein P3 (Foxp3) fusion protein. RESULTS: URO-OVA/OT-II mice failed to develop bladder infammation despite the presence of autoreactive CD4^+ T cells. By monitoring GFP-positive cells, bladder infltration of CD4^+ Treg cells was observed in URO-OVA^GFP-Foxp3/OT-II mice. The infiltrating Treg cells were functionally active and expressed Treg cell effector molecule as well as marker mRNAs including transforming growth factor-β, interleukin (IL)-10, fibrinogen-like protein 2, and glucocorticoid-induced tumor necrosis factor receptor (GITR). Studies further revealed that Treg cells from URO-OVA^GFP-Foxp3/OT-II mice were suppressive and inhibited autoreactive CD4^+ T cell proliferation and interferon (IFN)-g production in response to OVA Ag stimulation. Depletion of GITR-positive cells led to spontaneous development of bladder infammation and expression of inflammatory factor mRNAs for IFN-γ, IL-6, tumor necrosis factor-α and nerve growth factor in URO-OVA^GFP-Foxp3/OT-II mice. CONCLUSION: Treg cells specifc for bladder epithelial Ag play an important role in immunological homeostasis and the control of CD4^+ T cell-mediated bladder autoimmune infammation. 展开更多
关键词 BLADDER AUTOIMMUNITY Regulatory T cell cd4+ T cells antigen
下载PDF
CD44表达量对胶质母细胞瘤患者预后的影响分析
6
作者 张宇 马茜 +3 位作者 田少辉 方川 孔东生 冯世宇 《中国医刊》 CAS 2024年第10期1141-1144,共4页
目的探讨CD44表达量对胶质母细胞瘤(GBM)患者预后的影响。方法选取2021年7月1日至2023年8月31日解放军总医院第一医学中心收治的102例GBM患者为研究对象,以术中切除肿瘤组织CD44积分光密度(IOD)的平均值为分界线,将研究对象分为CD44高... 目的探讨CD44表达量对胶质母细胞瘤(GBM)患者预后的影响。方法选取2021年7月1日至2023年8月31日解放军总医院第一医学中心收治的102例GBM患者为研究对象,以术中切除肿瘤组织CD44积分光密度(IOD)的平均值为分界线,将研究对象分为CD44高表达组(IOD≥699023,51例)和CD44低表达组(IOD<699023,51例)。比较分析两组患者的一般资料、生存结局。采用单因素分析及Cox多因素回归方法分析GBM患者总生存率的影响因素。结果两组患者的性别、年龄比较差异均无统计学意义(P>0.05)。患者术后随访时间2.6~27.5个月,中位随访时间15.0个月,10例患者存活,其中CD44高表达组有3例患者存活,CD44低表达组有7例患者存活,CD44低表达组患者的中位总生存期为18.3个月,CD44高表达组患者的中位总生存期为13.6个月,log-rank检验结果显示,CD44低表达组患者的总生存率高于CD44高表达组(χ^(2)=22.233,P<0.001)。术后放化疗、手术切除程度、肿瘤性质、MGMT启动子甲基化状态、CD44表达量与GBM患者的总生存率显著相关(P<0.05)。Cox多因素回归分析结果显示,原发GEM、术后放化疗、完全切除、MGMT启动子甲基化、CD44低表达均为GBM患者总生存率的独立保护因素(P<0.05)。结论CD44表达量与GBM患者的预后显著相关,且CD44低表达为GBM患者总生存率的独立保护因素。 展开更多
关键词 胶质母细胞瘤 cd44表达量 总生存期
下载PDF
Cinnamon extract suppresses experimental colitis through modulation of antigen-presenting cells 被引量:7
7
作者 Ho-Keun Kwon Ji-Sun Hwang +8 位作者 Choong-Gu Lee Jae-Seon So Anupama Sahoo Chang-Rok Im Won Kyung Jeon Byoung Seob Ko Sung Haeng Lee Zee Yong Park Sin-Hyeog Im 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第8期976-986,共11页
AIM:To investigate the anti-inflammatory effects of cinnamon extract and elucidate its mechanisms for targeting the function of antigen presenting cells.METHODS:Cinnamon extract was used to treat murine macrophage cel... AIM:To investigate the anti-inflammatory effects of cinnamon extract and elucidate its mechanisms for targeting the function of antigen presenting cells.METHODS:Cinnamon extract was used to treat murine macrophage cell line(Raw 264.7),mouse primary antigen-presenting cells(APCs,MHCII+) and CD11c+dendritic cells to analyze the effects of cinnamon extract on APC function.The mechanisms of action of cinnamon extract on APCs were investigated by analyzing cytokine production,and expression of MHC antigens and co-stimulatory molecules by quantitative real-time PCR and flow cytometry.In addition,the effect of cinnamon extract on antigen presentation capacity and APC-dependent T-cell differentiation were analyzed by [H3]-thymidine incorporation and cytokine analysis,respectively.To confirm the anti-inflammatory effects of cinnamon extract in vivo,cinnamon or PBS was orally administered to mice for 20 d followed by induction of experimental colitis with 2,4,6 trinitrobenzenesulfonic acid.The protective effects of cinnamon extract against experimental colitis were measured by checking clinical symptoms,histological analysis and cytokine expression prof iles in inflamed tissue.RESULTS:Treatment with cinnamon extract inhibited maturation of MHCII+ APCs or CD11c+ dendritic cells(DCs) by suppressing expression of co-stimulatory molecules(B7.1,B7.2,ICOS-L),MHCII and cyclooxygenase(COX)-2.Cinnamon extract induced regulatory DCs(rDCs) that produce low levels of pro-inflammatory cytokines [interleukin(IL)-1β,IL-6,IL-12,interferon(IFN)-γ and tumor necrosis factor(TNF)-α] while expressing high levels of immunoregulatory cytokines(IL-10 and transforming growth factor-β).In addition,rDCs generated by cinnamon extract inhibited APC-dependent T-cell proliferation,and converted CD4+ T cells into IL-10high CD4+ T cells.Furthermore,oral administration of cinnamon extract inhibited development and progression of intestinal colitis by inhibiting expression of COX-2 and pro-inflammatory cytokines(IL-1β,IFN-γ and TNF-α),while enhancing IL-10 levels.CONCLUSION:Our study suggests the potential of cinnamon extract as an anti-inflammatory agent by targeting the generation of regulatory APCs and IL-10+ regulatory T cells. 展开更多
关键词 Cinnamon extract Inflammation cd4 antigen antigen presenting cells CYCLOOXYGENASE-2 Tumor necrosis factor-α INTERLEUKIN-10 Inflammatory bowel disease
下载PDF
CD44通过影响猪流行性腹泻病毒复制调节钠氢交换体3活性
8
作者 王静 张淑娟 +3 位作者 胡霞 刘向阳 张兴翠 宋振辉 《畜牧兽医学报》 CAS CSCD 北大核心 2024年第5期2176-2185,共10页
本研究旨在研究CD44(cluster of differentiation 44)对感染猪流行性腹泻病毒(porcine epidemic diarrhea virus, PEDV)的猪小肠上皮细胞(IPEC-J2)中钠氢交换体3(NHE3)表达及膜转移的影响。以IPEC-J2为细胞模型,采用RT-qPCR和Western b... 本研究旨在研究CD44(cluster of differentiation 44)对感染猪流行性腹泻病毒(porcine epidemic diarrhea virus, PEDV)的猪小肠上皮细胞(IPEC-J2)中钠氢交换体3(NHE3)表达及膜转移的影响。以IPEC-J2为细胞模型,采用RT-qPCR和Western blot检测感染PEDV后不同时间点IPEC-J2细胞中NHE3和PEDV N表达量变化;转染质粒调控IPEC-J2中CD44表达后,采用TCID50和Western blot检测PEDV感染后不同时间点PEDV复制水平和NHE3蛋白表达变化,采用火焰原子吸收法检测IPEC-J2细胞内外Na^(+)浓度变化。转录组数据和细胞试验结果显示,与对照组相比,PEDV感染后IPEC-J2细胞中CD44蛋白表达水平和mRNA表达量均呈上调趋势,24~48 h内上升显著(P<0.05),而PEDV N蛋白表达水平在12~48 h内则呈显著下降趋势(P<0.05)。此外,CD44重组质粒转染试验结果显示,与PEDV感染组相比,过表达CD44后感染PEDV组细胞中病毒滴度和PEDV N蛋白表达水平显著降低(P<0.05),而干扰CD44后感染PEDV组细胞中病毒滴度和PEDV N蛋白表达水平则显著上升(P<0.05)。以上结果表明,高表达CD44具有抑制PEDV复制的作用,干扰CD44后PEDV复制增多。同时,为研究PEDV感染情况下,CD44是否参与了IPEC-J2细胞中NHE3表达的调节,采用Western blot和火焰原子吸收法检测了调节CD44后膜NHE3蛋白的表达水平和细胞内外Na^(+)浓度。结果表明,过表达CD44显著促进了膜NHE3蛋白的表达和活性(P<0.05),细胞内外Na^(+)浓度逐渐恢复正常水平。相反,干扰CD44显著降低了膜NHE3蛋白的表达和活性(P<0.05),细胞内外Na^(+)浓度呈现失衡状态。结果提示,CD44可能是缓解PEDV引发仔猪腹泻的潜在治疗靶点,它通过抑制IPEC-J2细胞中PEDV的复制来增加转移至质膜上的NHE3数量,从而维持细胞内外Na^(+)运转平衡。 展开更多
关键词 cd44 猪流行性腹泻病毒 钠氢交换体3 钠离子
下载PDF
CD44异构体在HER23+阳性乳腺癌中的表达及其与预后的关系
9
作者 唐诗 温珮琦 +2 位作者 邓杰华 李凯恒 陈黛诗 《解放军医学院学报》 CAS 2024年第7期746-752,共7页
背景跨膜蛋白CD44与癌细胞侵袭和转移行为有密切关系,其异构体CD44v6和CD44v8-10在HER23+阳性乳腺癌中的作用尚不明确。目的分析CD44异构体CD44v6和CD44v8-10在HER23+阳性乳腺癌中的表达及其与预后的关系。方法收集2019年1月—2022年6... 背景跨膜蛋白CD44与癌细胞侵袭和转移行为有密切关系,其异构体CD44v6和CD44v8-10在HER23+阳性乳腺癌中的作用尚不明确。目的分析CD44异构体CD44v6和CD44v8-10在HER23+阳性乳腺癌中的表达及其与预后的关系。方法收集2019年1月—2022年6月就诊于东莞市妇幼保健院乳腺科经术前粗针穿刺活检确诊HER23+,并接受新辅助治疗后行手术切除的乳腺癌患者。应用免疫组织化学(IHC)对乳腺癌标本进行CD44v6和CD44v8-10染色,分析两者与HER2、雌激素受体、孕激素受体等临床病理特征和病理完全缓解(pathologic complete response,pCR)之间的关系。结果86例HER23+阳性乳腺癌患者年龄(46.99±10.01)岁,均为女性。全部患者均表现出CD44异构体异质性表达,其中55例(64.0%)CD44v6高表达,58例(67.4%)CD44v8-10高表达。CD44v6高表达组的ER阳性率(76.4%vs 48.4%,P=0.017)、PR阳性率(78.2%vs 19.4%,P<0.001)和Ki67阳性指数(81.8%vs 61.3%,P=0.043)均高于CD44v6低表达组,差异有统计学意义。CD44v8-10高表达组的PR阳性率(70.7%vs 28.6%,P<0.001)和淋巴结转移发生率(72.4%vs 14.3%,P<0.001)均高于CD44v8-10低表达组,差异有统计学意义。此外,CD44v6低表达组和CD44v8-10低表达组的pCR率均显著高于CD44v6高表达组(54.8%vs 30.9%,P=0.039)和CD44v8-10高表达组(71.4%vs 24.1%,P<0.001),差异有统计学意义。多因素Logistic回归分析显示HER2弥漫3+和CD44v8-10高表达的患者pCR率更低(OR=5.281,95%CI:1.346~20.718,P=0.017;OR=5.062,95%CI:1.232~20.799,P=0.024)。结论CD44异构体与HER23+阳性乳腺癌的恶性特征相关,CD44v8-10可作为HER2弥漫3+预后不良的标志物。 展开更多
关键词 cd44 异构体 HER2 乳腺癌 预后
下载PDF
SMAD3和CD44在甲状腺乳头状癌组织中的表达水平与临床病理特征及预后的关系
10
作者 刘延彬 左丽娟 +3 位作者 辛运超 刘亚超 田泽东 尚小领 《中国耳鼻咽喉颅底外科杂志》 CAS CSCD 2024年第5期83-88,共6页
目的探讨信号转导分子3(SMAD3)和白细胞分化抗原44(CD44)在甲状腺乳头状癌(PTC)组织中的表达水平与临床病理特征及预后的关系。方法选取2019年6月-2020年6月收治的PTC患者88例为研究对象,同期取距离癌组织3 cm以上癌旁组织作为对照,实... 目的探讨信号转导分子3(SMAD3)和白细胞分化抗原44(CD44)在甲状腺乳头状癌(PTC)组织中的表达水平与临床病理特征及预后的关系。方法选取2019年6月-2020年6月收治的PTC患者88例为研究对象,同期取距离癌组织3 cm以上癌旁组织作为对照,实时荧光定量PCR(qRT-PCR)检测SMAD3和CD44的mRNA表达水平;免疫组化法检测SMAD3和CD44的阳性表达情况。Spearman相关性分析PTC患者癌组织中SMAD3和CD44的mRNA表达水平的关系。SMAD3和CD44与PTC患者预后的关系采用Kaplan-Meier法进行分析。COX回归分析影响PTC患者预后的危险因素。结果与癌旁组织相比,PTC组SMAD3的表达水平显著降低(t=8.484,P<0.05),CD44表达水平显著升高(t=11.232,P<0.05)。相关性分析显示,PTC患者癌组织中SMAD3和CD44的mRNA表达水平呈负相关(r s=-0.519,P<0.05)。与癌旁组织相比,PTC组SMAD3阳性表达率显著降低(χ^(2)=41.905,P<0.05),CD44阳性表达率显著升高(χ^(2)=62.888,P<0.05)。SMAD3表达与TNM分期(χ^(2)=7.678,P=0.006)、淋巴结转移(χ^(2)=20.398,P<0.05)、侵犯包膜(χ^(2)=9.881,P=0.002)有关。CD44表达与TNM分期(χ^(2)=3.959,P=0.047)、淋巴结转移(χ^(2)=20.702,P<0.05)、侵犯包膜(χ^(2)=10.363,P=0.001)有关。术后随访3年发现,SMAD3阳性表达PTC患者生存率高于阴性表达患者生存率(χ^(2)=4.644,P=0.031)。CD44阳性表达PTC患者生存率显著低于阴性表达患者生存率(χ^(2)=5.331,P=0.021)。多因素COX回归分析显示,淋巴结转移、SMAD3和CD44表达是影响PTC患者预后的危险因素(P<0.05)。结论PTC组织中SMAD3呈异常低表达,CD44呈高表达,其水平与PTC患者临床病理特征及预后有关。 展开更多
关键词 甲状腺乳头状癌 信号转导分子3 白细胞分化抗原44 预后 临床病理特征
下载PDF
苏木对肺癌干细胞荷瘤小鼠原发肿瘤CD44v6表达的影响
11
作者 韩海英 郭秀伟 《辽宁中医杂志》 CAS 北大核心 2024年第6期189-192,I0010,共5页
目的研究苏木对肺癌干细胞样细胞PG-BE1荷瘤小鼠原发瘤中CD44v6蛋白表达的影响。方法利用无血清培养法分选PG-BE1细胞中的干细胞样细胞,将干细胞样细胞亚群接种于小鼠下肢脚垫。采用药物对小鼠进行干预,第21天剥取小鼠原发瘤组织,采用We... 目的研究苏木对肺癌干细胞样细胞PG-BE1荷瘤小鼠原发瘤中CD44v6蛋白表达的影响。方法利用无血清培养法分选PG-BE1细胞中的干细胞样细胞,将干细胞样细胞亚群接种于小鼠下肢脚垫。采用药物对小鼠进行干预,第21天剥取小鼠原发瘤组织,采用Western Blot法、免疫组化法检测原发瘤组织CD44v6的表达。结果原发瘤重方面,苏木联合顺铂组较空白组、苏木组和顺铂组减少(P<0.05)。苏木加顺铂组较顺铂组、苏木组、空白组CD44V6表达较少(P<0.05)。免疫组化法检测苏木在原发瘤组织中CD44v6均有表达。结论苏木可以协同顺铂减少CD44v6蛋白的表达从而增加肺癌干细胞样细胞荷瘤小鼠模型原发肿瘤的抑瘤率。 展开更多
关键词 苏木 肿瘤干细胞 cd44V6
下载PDF
CD44的生物特征及在恶性肿瘤中的研究进展
12
作者 田思岳 范志勤 《临床医学进展》 2024年第6期1490-1494,共5页
CD44是一种复杂的跨膜糖蛋白,在肿瘤干细胞上过度表达。CD44表达失调与肿瘤发生和发展有关。CD44参与多种重要信号通路的调控,与肿瘤增殖、侵袭、转移和治疗耐药密切相关。CD44过度表达抑制化疗药物在多种癌症中的细胞毒作用。因此,CD4... CD44是一种复杂的跨膜糖蛋白,在肿瘤干细胞上过度表达。CD44表达失调与肿瘤发生和发展有关。CD44参与多种重要信号通路的调控,与肿瘤增殖、侵袭、转移和治疗耐药密切相关。CD44过度表达抑制化疗药物在多种癌症中的细胞毒作用。因此,CD44可以作为癌症患者的不良预后标志物。CD44过度表达为化疗耐药患者的治疗干预提供新的分子靶点。本篇综述重点概述CD44的结构功能,CD44在肿瘤细胞干性和肿瘤发生发展中的作用,及与癌症患者预后的关系。 展开更多
关键词 cd44 恶性肿瘤 癌症干细胞 预后
下载PDF
血清miR-133a、sCD44v6、胃泌素-17在胃癌和癌前病变筛查中的应用及与Hp-IgG表达的关系 被引量:1
13
作者 陈群 陈希 《临床和实验医学杂志》 2024年第4期361-366,共6页
目的 探究血清微小RNA-133a(miR-133a)、可溶性CD44变体6(sCD44v6)和胃泌素-17在胃癌和癌前病变筛查中的应用,并研究其与幽门螺杆菌-免疫球蛋白G(Hp-IgG)表达的关系。方法 回顾性选取2020年1月至2023年1月在重庆市开州区人民医院就诊的... 目的 探究血清微小RNA-133a(miR-133a)、可溶性CD44变体6(sCD44v6)和胃泌素-17在胃癌和癌前病变筛查中的应用,并研究其与幽门螺杆菌-免疫球蛋白G(Hp-IgG)表达的关系。方法 回顾性选取2020年1月至2023年1月在重庆市开州区人民医院就诊的胃癌患者103例(胃癌组)、癌前病变患者112例(癌前病变组)及同期在本院进行体检的健康志愿者100名(对照组)作为本次研究对象。收集各组对象的血清miR-133a、sCD44v6、胃泌素-17水平,并探究其对胃癌及癌前病变筛查的诊断价值。比较癌前病变组及胃癌组患者Hp-IgG检测结果,并分析胃癌组及癌前病变组Hp-IgG阳性率与血清miR-133a、sCD44v6、胃泌素-17水平的相关性。结果 癌前病变组、胃癌组患者血清miR-133a相对表达水平低于对照组,sCD44v6、胃泌素-17水平高于对照组,且胃癌组血清miR-133a相对表达水平低于癌前病变组,sCD44v6、胃泌素-17水平高于癌前病变组,差异均有统计学意义(P<0.05)。血清miR-133a相对表达水平、sCD44v6、胃泌素-17水平诊断癌前病变的曲线下面积(AUC)值分别为0.621、0.932、0.945(P<0.05)。血清miR-133a相对表达水平、sCD44v6、胃泌素-17水平诊断胃癌的AUC值分别为0.864、0.876、0.845(P<0.05)。胃癌组患者的Hp-IgG阳性率为79.61%,高于癌前病变组(41.07%),差异有统计学意义(P<0.05)。癌前病变组患者的Hp-IgG阳性率与血清miR-133a相对表达水平无明显相关性(r=-0.065,P>0.05),与sCD44v6、胃泌素-17水平呈正相关(r=0.404、0.344,P<0.05)。胃癌组患者的Hp-IgG阳性率与血清miR-133a相对表达水平呈负相关(r=-0.693,P<0.05),与sCD44v6、胃泌素-17水平呈正相关(r=0.765、0.766,P<0.05)。结论 在胃癌和癌前病变中,血清miR-133a的相对表达水平较低,而sCD44v6和胃泌素-17的水平较高,且具有一定诊断价值,可用于胃癌和癌前病变的筛查。胃癌患者的Hp-IgG阳性率较高,并且与血清miR-133a呈负相关,与sCD44v6和胃泌素-17呈正相关。在癌前病变患者中,Hp-IgG阳性率与血清miR-133a相对表达水平无明显相关性,但与sCD44v6和胃泌素-17的水平呈正相关,应密切关注Hp-IgG在患者中的表达情况。 展开更多
关键词 微小RNA-133a 可溶性cd44变体6 胃泌素-17 胃癌 癌前病变 幽门螺杆菌-免疫球蛋白G
下载PDF
The human leucocyte differentiation antigens (HLDA) workshops: the evolv-ing role of antibodies in research, diagnosis and therapy 被引量:2
14
作者 Heddy ZOLA Bernadette SWART 《Cell Research》 SCIE CAS CSCD 2005年第9期691-694,共4页
The 8^th International Workshop on Human Leucocyte Differentiation Antigens (chaired by HZ and managed by BS) was run over a 4-year period and culminated in a conference in December 2004. Here we review the achievem... The 8^th International Workshop on Human Leucocyte Differentiation Antigens (chaired by HZ and managed by BS) was run over a 4-year period and culminated in a conference in December 2004. Here we review the achievements of the HLDA Workshops and provide links to information on CD molecules and antibodies against them, including the 93 new CDs assigned in the 8^th Workshop. We consider what remains to be achieved (including an estimate of the number of leucocyte surface molecules still to be discovered), and how the field can best move forward. 展开更多
关键词 leucocyte differentiation antigens cd molecules cell markers
下载PDF
Impact of PRRSV on activation and viability of antigen presenting cells 被引量:4
15
作者 Irene M Rodríguez-Gómez Jaime Gómez-Laguna Librado Carrasco 《World Journal of Virology》 2013年第4期146-151,共6页
Porcine reproductive and respiratory syndrome(PRRS) is one of the most important diseases of swine industry. The causal agent, PRRS-virus(PRRSV), is able to evade the host immune response and survive in the organism c... Porcine reproductive and respiratory syndrome(PRRS) is one of the most important diseases of swine industry. The causal agent, PRRS-virus(PRRSV), is able to evade the host immune response and survive in the organism causing transient infections. Despite all scientific efforts, there are still some gaps in the knowledge of the pathogenesis of this disease. Antigen presenting cells(APCs), as initiators of the immune response, are located in the first line of defense against microorganisms, and are responsible for antigen recognition, processing and presentation. Dendritic cells(DCs) are the main type of APC involved in antigen presentation and they are susceptible to PRRSV infection. Thus, PRRSV replication in DCs may trigger off different mechanisms to impair the onset of a host effective immune response against the virus. On the one side, PRRSV may impair the basic functions of DCs by regulating the expression of major histocompatibility complex class Ⅱ and CD80/86. Other strategy followed by the virus is the induction of cell death of APCs by apoptosis, necrosis or both of them. The impairment and/or cell death ofAPCs could lead to a failure in the onset of an efficient immune response, as long as cells could not properly activate T cells. Future aspects to take into account are also discussed in this review. 展开更多
关键词 Porcine REPRODUCTIVE and respiratory syndrome antigen PRESENTING CELLS DENDRITIC CELLS Immune response Major HISTOCOMPATIBILITY complex classⅡ cd80/86 Cell death Apoptosis
下载PDF
编码基因/非编码基因调控CD44在多种肿瘤耐药机制中的研究进展
16
作者 陈琛 高亮 +1 位作者 孙依鹏 陈敬华 《西南民族大学学报(自然科学版)》 CAS 2024年第5期524-533,共10页
多种肿瘤(胰腺癌,肺癌,结直肠癌等)长效耐药细胞显著增强其转移性,且诱导CD44蛋白表达.CD44是一种非激酶受体,在多种肿瘤中作为肿瘤干细胞标记物在侵袭和转移中发挥重要作用.早期联合一线化疗药和靶向CD44的药物、探索靶向CD44的合理给... 多种肿瘤(胰腺癌,肺癌,结直肠癌等)长效耐药细胞显著增强其转移性,且诱导CD44蛋白表达.CD44是一种非激酶受体,在多种肿瘤中作为肿瘤干细胞标记物在侵袭和转移中发挥重要作用.早期联合一线化疗药和靶向CD44的药物、探索靶向CD44的合理给药时间点可能提升临床已转移的恶性肿瘤患者的总体生存率.从编码基因(转录因子、异质核糖核蛋白、上皮剪接调节蛋白、细胞因子以及蛋白激酶)和非编码基因(LncRNA、miRNA和circRNA)两方面介绍CD44上游调控因子介导的肿瘤耐药和转移机制.此外,还总结在耐药肿瘤细胞中CD44的亚型转换、表达调控、CD44下游效应分子的信号通路和CD44作为癌症治疗靶点的临床意义. 展开更多
关键词 cd44 耐药 癌症 非编码RNA 基因调控
下载PDF
Key role of human leukocyte antigen in modulating human immunodeficiency virus progression: An overview of the possible applications 被引量:1
17
作者 Alba Grifoni Carla Montesano +1 位作者 Vittorio Colizzi Massimo Amicosante 《World Journal of Virology》 2015年第2期124-133,共10页
Host and viral factors deeply influence the human immunodeficiency virus(HIV) disease progression. Among them human leukocyte antigen(HLA) locus plays a key role at different levels. In fact, genes of the HLA locus ha... Host and viral factors deeply influence the human immunodeficiency virus(HIV) disease progression. Among them human leukocyte antigen(HLA) locus plays a key role at different levels. In fact, genes of the HLA locus have shown the peculiar capability to modulate both innate and adaptive immune responses. In particular, HLA class Ⅰmolecules are recognized by CD8+ T-cells and natural killers(NK) cells towards the interaction with T cell receptor(TCR) and Killer Immunoglobulin Receptor(KIR) 3DL1 respectively. Polymorphisms within the different HLA alleles generate structural changes in HLA classⅠpeptide-binding pockets. Amino acid changes in the peptide-binding pocket lead to the presentation of a different set of peptides to T and NK cells. This review summarizes the role of HLA in HIV progression toward acquired immunodeficiency disease syndrome and its receptors. Recently, many studies have been focused on determining the HLA binding-peptides. The novel use of immune-informatics tools, from the prediction of the HLA-bound peptides to the modification of the HLAreceptor complexes, is considered. A better knowledge of HLA peptide presentation and recognition are allowing new strategies for immune response manipulation to be applied against HIV virus. 展开更多
关键词 HUMAN IMMUNODEFICIENCY virus PROGRESSION HUMAN LEUKOCYTE antigen EPITOPE IMMUNOINFORMATICS cd8+T lymphocytes
下载PDF
白血病抑制因子通过调控CD44的表达增强结直肠癌细胞干性特征
18
作者 邱芬 郗雪艳 杜伯雨 《中国病理生理杂志》 CAS CSCD 北大核心 2024年第10期1826-1833,共8页
目的:探讨白血病抑制因子(leukemia inhibitory factor,LIF)通过调控肿瘤干细胞(cancer stem cells,CSCs)分子标志物CD44的表达增强结直肠癌(colorectal cancer,CRC)细胞干性特征的分子机制。方法:利用TCGA公共数据库和RNAscope原位杂... 目的:探讨白血病抑制因子(leukemia inhibitory factor,LIF)通过调控肿瘤干细胞(cancer stem cells,CSCs)分子标志物CD44的表达增强结直肠癌(colorectal cancer,CRC)细胞干性特征的分子机制。方法:利用TCGA公共数据库和RNAscope原位杂交方法分析LIF基因在CRC组织中的表达情况;应用慢病毒感染系统构建稳定敲减LIF的CRC细胞系(HCT116和Caco2细胞);实验分CRC细胞对照组、CRC细胞添加LIF组、CRC细胞敲减LIF对照组和CRC细胞敲减LIF组;应用干细胞成球实验、MTT、RTCA、平板集落及迁移实验检测LIF对CRC细胞的影响;应用RT-qPCR和Western blot检测LIF对CRC肿瘤球细胞干性相关标志物CD44和转录因子ELF3表达的影响;应用RT-qPCR检测敲减LIF后CD44剪接变异体的表达变化。结果:CRC组织中LIF的表达水平高于癌旁组织(P<0.01),且LIF高表达的CRC患者无病生存期缩短(P<0.05),外源性LIF可增强CRC细胞的成球、增殖和迁移能力(P<0.05),敲减LIF可抑制CRC细胞的增殖和迁移(P<0.05)。外源性LIF可上调CRC肿瘤球细胞CD44的表达(P<0.05),而敲减LIF可抑制CD44的表达(P<0.01),同时CD44剪接变异体的转录水平降低。外源性添加LIF和敲减LIF可分别增强和降低转录因子ELF3的表达水平(P<0.05)。结论:LIF通过上调转录因子ELF3,增强CRC细胞CD44的表达,进而增强CRC细胞的干性特征,促进CRC细胞的恶性进展。 展开更多
关键词 白血病抑制因子 结直肠癌 干性 cd44 ELF3
下载PDF
CD44蛋白在胃癌中的表达情况及临床意义分析
19
作者 陈廷玥 李明 《中外医药研究》 2024年第13期48-50,共3页
目的:分析胃癌中白细胞分化抗原44(CD44)蛋白的表达情况与临床意义。方法:回顾性分析2019年1月—2022年1月于苏州市立医院接受手术治疗的胃癌患者139例的临床资料,并采用免疫组织化学法检测患者胃癌组织病理标本中CD44蛋白表达情况。分... 目的:分析胃癌中白细胞分化抗原44(CD44)蛋白的表达情况与临床意义。方法:回顾性分析2019年1月—2022年1月于苏州市立医院接受手术治疗的胃癌患者139例的临床资料,并采用免疫组织化学法检测患者胃癌组织病理标本中CD44蛋白表达情况。分析CD44蛋白表达情况与临床病理特征及预后的关系。结果:胃癌组织中CD44蛋白表达率高于正常胃黏膜组织,差异有统计学意义(P<0.001)。阳性病例中,低分化胃癌患者CD44蛋白免疫组化评分高于高/中分化胃癌患者,肿瘤最大径≥4 cm胃癌患者CD44蛋白免疫组化评分高于肿瘤最大径<4 cm胃癌患者,差异有统计学意义(P<0.001);CD44蛋白阳性与CD44蛋白阴性胃癌患者性别、年龄、Lauren分型比较,差异无统计学意义(P>0.05);CD44蛋白阳性胃癌患者肿块最大径≥4 cm、低分化、血管侵犯阳性、淋巴结转移阳性、TNM分期为Ⅲ或Ⅳ期占比高于CD44蛋白阴性者,差异有统计学意义(P<0.05);CD44阳性表达者生存期短于阴性表达者,差异有统计学意义(P=0.003)。结论:不同分化程度、肿瘤最大径的胃癌患者CD44蛋白表达存在明显差异,CD44蛋白阳性与CD44蛋白阴性胃癌患者肿块最大径、分化程度、血管侵犯情况、淋巴结转移情况、TNM分期存在明显差异,可将CD44蛋白作为胃癌浸润、转移及判读预后的生物学标记物。 展开更多
关键词 胃癌 白细胞分化抗原44 肿瘤干细胞标记物
下载PDF
双花坤孕方配合孕三烯酮对子宫内膜异位症患者血清CD44及TNF-α的影响
20
作者 卢青玉 贾红伟 《河北医药》 CAS 2024年第16期2484-2487,共4页
目的探讨双花坤孕方配合孕三烯酮对子宫内膜异位症患者血清CD44及TNF-α的影响。方法选择2022年5月至2023年4月,收治的90例子宫内膜异位症患者,随机分为对照组和观察组,每组45例。对照组给予孕三烯酮治疗,观察组给予双花坤孕方配合孕三... 目的探讨双花坤孕方配合孕三烯酮对子宫内膜异位症患者血清CD44及TNF-α的影响。方法选择2022年5月至2023年4月,收治的90例子宫内膜异位症患者,随机分为对照组和观察组,每组45例。对照组给予孕三烯酮治疗,观察组给予双花坤孕方配合孕三烯酮治疗。比较2组治疗前后免疫功能情况;比较2组治疗前后性激素水平变化情况;比较2组治疗前后血清CD44及TNF-α水平变化情况;比较2组疗效症状评分及不良反应情况。结果治疗后,2组血清IgA、Ig G、IgM水平均降低(P<0.05),且观察组更明显(P<0.05);治疗后,2组促卵泡激素(FSH)、黄体生成素(LH)、孕酮(P)、雌二醇(E2)水平均降低(P<0.05),且观察组更明显(P<0.05);治疗后,2组血清CD44及TNF-α水平均下降,且观察组更明显(P<0.05);观察组疗效优于对照组(P<0.05)。观察组症状评分及总分均低于对照组(P<0.05)。2组患者药物不良反应无明显差异(P>0.05)。结论对子宫内膜异位症患者给予双花坤孕方配合孕三烯酮治疗,可提高免疫力,改善异常的性激素水平,降低血清CD44及TNF-α水平,改善临床症状,疗效显著,且安全可靠。 展开更多
关键词 双花坤孕方 孕三烯酮 子宫内膜异位症 cd44 TNF-Α
下载PDF
上一页 1 2 190 下一页 到第
使用帮助 返回顶部